Abstract
The C3d fragment of complement component C3 has been shown to enhance immune responses to antigens that lack T-cell epitopes such as bacterial polysaccharides. C3d binds to the B-cell complement receptor 2 (CR2 or CD21); this binding serves as a co-activation signal to the B cell when the polysaccharide antigen portion binds simultaneously to the B-cell receptor (surface Ig). Bringing together receptor-associated signal transduction molecules CD19 and Igalpha/beta, respectively, results in a lower threshold of activation. Paradoxically, C3d has also been shown to enhance antibody titers in the CD21 knockout (KO) mouse model as well as increase Th1 and Th2 cytokine secretion, suggesting that that an auxiliary CR2-independent pathway of immune activation may exist. We hypothesized that in addition to its molecular adjuvant property that enhances signal 1 during B-cell activation (co-signal 1), C3d also contains T-cell epitopes that are able to stimulate autoreactive C3d peptide-specific helper T cells which we term 'co-signal 2'. Using the EpiMatrix T-cell epitope-mapping algorithm, we identified 11 putative T-cell epitopes in C3d, a very high epitope density for a 302 amino-acid sequence. Eight of these epitope candidates were s...Continue Reading
References
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J D LambrisH J Müller-Eberhard
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M H de Bruijn, G H Fey
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·G T WilliamsM S Neuberger
Jan 19, 1996·Science·P W DempseyD T Fearon
May 1, 1996·AIDS Research and Human Retroviruses·C G RobertsA S De Groot
May 1, 1997·AIDS Research and Human Retroviruses·A S De GrootG Deocampo
Jun 3, 2000·Annual Review of Immunology·D T Fearon, M C Carroll
Apr 9, 2001·Infection and Immunity·S T TestA H Lucas
Jun 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A CherukuriS K Pierce
Aug 3, 2001·Vaccine·A S De GrootC Saint-Aubin
Aug 13, 2002·Nature Immunology·Chang-You WuRobert A Seder
Jul 19, 2003·Scandinavian Journal of Immunology·H Jakobsen, I Jonsdottir
Sep 25, 2003·Vaccine·Anne S De GrootKenneth H Mayer
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karen M HaasThomas F Tedder
May 26, 2004·Molecular Immunology·Michael C Carroll
Apr 4, 2006·Drug Discovery Today·Anne S De Groot
Apr 6, 2006·The Journal of Experimental Medicine·Allen C SteereLee Ann Baxter-Lowe
Aug 9, 2006·Advances in Experimental Medicine and Biology·Joseph F Bower, Ted M Ross
Apr 21, 2007·Cellular Immunology·Anne S De GrootWilliam Martin
May 11, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·E KorenW Martin
Citations
Jun 23, 2009·Cancer Immunology, Immunotherapy : CII·Pei-he LiangFeng-shuo Jin
Jul 21, 2012·Bioconjugate Chemistry·Raymond P BrinãsJoseph J Barchi
Jul 29, 2008·Blood·Anne S De GrootWilliam Martin
Jun 28, 2012·Journal of Pharmaceutical Sciences·Richard Johnson, Wim Jiskoot
Nov 12, 2014·Immunology and Cell Biology·Anne S De GrootPaul M Knopf
May 16, 2017·PloS One·Nawal Bahia El IdrissiPranab K Das
Jan 30, 2010·American Journal of Rhinology & Allergy·Rodney J SchlosserCarl Atkinson
Feb 2, 2019·Expert Review of Vaccines·Hannah G KellyAdam K Wheatley
Sep 16, 2018·The Journal of Biological Chemistry·Amy J OsborneStephen J Perkins
May 16, 2013·Organic & Biomolecular Chemistry·Lorena Simón-GraciaMiriam Royo
Aug 1, 2020·Frontiers in Immunology·Jack MellorsMiles Carroll
May 5, 2017·JCI Insight·Jeffrey L PlattMarilia Cascalho
Apr 23, 2020·Advanced Drug Delivery Reviews·Farjana KhatunRachel J Stephenson
Aug 1, 2021·Journal of Biomedical Materials Research. Part a·Feiyang CaiXing Jiang